Contact Us

Resources

Publication: The Multifunctional Role of Poloxamer P338 as a Biofilm Disrupter and Antibiotic Enhancer: A Small Step forward against the Big Trouble of Catheter-Associated Escherichia coli Urinary Tract Infections

View or download the Publication to read more
De Angelis et al. used a BioFlux Shear Flow System with silicone bottom plates to investigate the use of poloxamer 388 (P338) as an anti-biofilm compound that can be used to manage catheter-associated urinary tract infections. The group found that a 0.5% P338 solution was able to reduce Escherichia coli volume and area up to 50% and disaggregate biofilms up to 34%.

Related Resources

Distinct and convergent effects of SF3B1 mutations in human breast cancer

In this study, CellRaft AIR was used to isolate, verify, and expand monoclonal cell lines carrying engineered SF3B1 mutations, forming the basis of an isogenic...

Learn more

A benchmark of the somatic mutation landscape using single-cell and single-molecule whole-genome sequencing

In this work, CellRaft arrays were used to generate clonally derived cell populations from single cells prior to sequencing, providing a ground-truth reference for benchmarking...

Learn more

Loss of cell cycle gatekeeping by CNOT3 impairs hematopoietic stem and progenitor cell division and repopulating activity

In this study, CellRaft AIR was used to isolate and track single hematopoietic stem and progenitor cell (HSPC) clones over time, enabling researchers to directly...

Learn more
See all Publications